perfluoroperhydrophenanthrene

phenanthrene, tetracosafluorotetradecahydro-

CAS: 306-91-2 C14 F24 MW: 624.11567680

Identification

Nameperfluoroperhydrophenanthrene
CAS Number306-91-2
FDA UNIIZZ3T53GWV9
Molecular FormulaC14 F24
Molecular Weight624.11567680
MDL NumberMFCD00042596
Nikkaji NumberJ93.658H
Beilstein2514226

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 210.00 °C. @ 760.00 mm Hg
Vapor Pressure 0.200000 mmHg @ 25.00 °C. (est)
Flash Point 184.00 °F. TCC ( 84.50 °C. ) (est)
logP (o/w) 8.410 (est)
Soluble in water, 8.702e-006 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorycosmetic agents
Recommendation for perfluoroperhydrophenanthrene usage levels up tonot for fragrance use.
Recommendation for perfluoroperhydrophenanthrene flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

per fluoro(perhydrophenanthrene) per fluoro(tetradecahydrophenanthrene) flutec PP11 phenanthrene, 1,1,2,2,3,3,4,4,4a,4b,5,5,6,6,7,7,8,8,8a,9,9,10,10,10a-tetracosafluorotetradecahydro- phenanthrene, tetracosafluorotetradecahydro- 1,1,2,2,3,3,4,4,4a,4b,5,5,6,6,7,7,8,8,8a,9,9,10,10,10a- tetracosafluorophenanthrene tetracosafluorotetradecahydrophenanthrene PubMed: An update: improvements in imaging perfluorocarbon-mounted plant leaves with implications for studies of plant pathology, physiology, development and cell biology. PubMed: Highly selective detection of silver in the low ppt range with ion-selective electrodes based on ionophore-doped fluorous membranes. PubMed: Solvation of halogens in fluorous phases. Experimental and simulation data for F2, Cl2, and Br2 in several fluorinated liquids. PubMed: Fluorophilic ionophores for potentiometric pH determinations with fluorous membranes of exceptional selectivity. PubMed: Fluorous bulk membranes for potentiometric sensors with wide selectivity ranges: observation of exceptionally strong ion pair formation. PubMed: Management of traumatic retinal detachment with vitreon in children. PubMed: Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery. PubMed: Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair. PubMed: Use of perfluorocarbon liquids, silicone oil, and 5-fluorouracil in the management of experimental PVR. PubMed: Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. PubMed: Intraocular pressure changes in the vitreon study. PubMed: Intraoperative complications of perfluoroperhydrophenanthrene: subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon. Vitreon Study Group. PubMed: The adjunctive use of perfluoroperhydrophenanthrene (Vitreon) in diabetic vitrectomy. PubMed: Tolerance of extended-term vitreous replacement with perfluoro-n-octane and perfluoroperhydrophenanthrene mixture (phenoctane). PubMed: Effects of the long-term use of perfluoroperhydrophenanthrene on the retina. PubMed: The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. PubMed: Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group. PubMed: An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study. PubMed: Postoperative chronic pressure abnormalities in the vitreon study. PubMed: Posttransplantation function of hearts preserved with fluorochemical emulsion. PubMed: Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group. PubMed: Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method. PubMed: Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study. PubMed: Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery. PubMed: Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. PubMed: Perfluorocarbon liquid in traumatic vitreous hemorrhage and retinal detachment. PubMed: Perfluoroperhydrophenanthrene (Vitreon) is radiopaque. PubMed: Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon). PubMed: Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages. PubMed: Surgical management of incarcerated retina in the sclerotomy. PubMed: Fluorochemical emulsion APE-LM substantially improves cardiac preservation. PubMed: Management of retinal detachment associated with choroidal coloboma using perfluoroperhydrophenanthrene (Vitreon). PubMed: Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids.